ES8303423A1 - Un procedimiento para preparar compuestos de cefem - Google Patents

Un procedimiento para preparar compuestos de cefem

Info

Publication number
ES8303423A1
ES8303423A1 ES505257A ES505257A ES8303423A1 ES 8303423 A1 ES8303423 A1 ES 8303423A1 ES 505257 A ES505257 A ES 505257A ES 505257 A ES505257 A ES 505257A ES 8303423 A1 ES8303423 A1 ES 8303423A1
Authority
ES
Spain
Prior art keywords
processes
preparation
cephem compounds
compound
new cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505257A
Other languages
English (en)
Other versions
ES505257A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8303423A1 publication Critical patent/ES8303423A1/es
Publication of ES505257A0 publication Critical patent/ES505257A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE CEFEM Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES AMINO O AMINO PROTEGIDO; R ES UN RADICAL HETEROMONOCICLICO C <- QUE CONTIENE UN ATOMO DE AZUFRE; R ES CARBOXI O CARBOXI PROTEGIDO; Y R PUEDE SER VARIOS RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), O SU DERIVADO REACTIVO EN EL GRUPO AMINO O UNA DE SUS SALES, CON UN COMPUESTO DE FORMULA (III), O SU DERIVADO REACTIVO EN EL GRUPO CARBOXI O UNA DE SUS SALES, FORMULAS EN LAS QUE R -R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE REALIZA EN UN DISOLVENTE INERTE, EN PRESENCIA DE UN AGENTE DE CONDENSACION, A LA TEMPERATURA AMBIENTE O INFERIOR. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS ACTIVIDADES ANTIMICROBIANAS.
ES505257A 1980-09-08 1981-09-07 Un procedimiento para preparar compuestos de cefem Granted ES505257A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8028933 1980-09-08

Publications (2)

Publication Number Publication Date
ES8303423A1 true ES8303423A1 (es) 1983-02-01
ES505257A0 ES505257A0 (es) 1983-02-01

Family

ID=10515925

Family Applications (2)

Application Number Title Priority Date Filing Date
ES505257A Granted ES505257A0 (es) 1980-09-08 1981-09-07 Un procedimiento para preparar compuestos de cefem
ES514654A Granted ES514654A0 (es) 1980-09-08 1982-08-02 "un procedimiento para preparar un compuesto de cefem".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES514654A Granted ES514654A0 (es) 1980-09-08 1982-08-02 "un procedimiento para preparar un compuesto de cefem".

Country Status (6)

Country Link
US (2) US4416879A (es)
EP (2) EP0184227B1 (es)
JP (2) JPS5777689A (es)
AT (2) ATE50575T1 (es)
DE (2) DE3176274D1 (es)
ES (2) ES505257A0 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405617A (en) * 1980-02-11 1983-09-20 Fujisawa Pharmaceutical Co., Ltd. 3-(Propynyltetrazol)thiomethyl-3-cephems
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS5946292A (ja) * 1982-09-09 1984-03-15 Otsuka Chem Co Ltd 2−置換セフエム誘導体の製造法
US4608373A (en) * 1982-12-13 1986-08-26 Yamanouchi Pharmaceutical Co., Ltd. Cephem compounds
CA1267647A (en) * 1984-12-27 1990-04-10 Ryosuke Ushijima Cephalosporin derivatives
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
US6559430B2 (en) 2001-01-04 2003-05-06 General Mills, Inc. Foil edge control for microwave heating
EP3616695A1 (en) 2011-09-09 2020-03-04 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2716677C2 (de) 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4288435A (en) * 1978-07-17 1981-09-08 Fujisawa Pharmaceutical Co., Ltd. 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds and pharmaceutical antibacterial compositions containing them
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
GB2028305A (en) * 1978-08-03 1980-03-05 Hoechst Ag Cephem derivatives and processes for their manufacture
JPS55105689A (en) * 1978-12-29 1980-08-13 Fujisawa Pharmaceut Co Ltd Novel cephem and cepham compounds, their preparation and preventive and remedy for microbism
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
ES8307825A1 (es) 1983-07-01
DE3176274D1 (en) 1987-07-30
JPS5777689A (en) 1982-05-15
ATE50575T1 (de) 1990-03-15
EP0184227B1 (en) 1990-02-28
EP0047491A2 (en) 1982-03-17
DE3177159D1 (de) 1990-04-05
EP0184227A1 (en) 1986-06-11
ES505257A0 (es) 1983-02-01
EP0047491B1 (en) 1987-06-24
US4533738A (en) 1985-08-06
JPH0327552B2 (es) 1991-04-16
EP0047491A3 (en) 1983-03-16
JPS6393781A (ja) 1988-04-25
ATE27956T1 (de) 1987-07-15
US4416879A (en) 1983-11-22
JPH0158191B2 (es) 1989-12-11
ES514654A0 (es) 1983-07-01

Similar Documents

Publication Publication Date Title
ES8307825A1 (es) &#34;un procedimiento para preparar un compuesto de cefem&#34;.
ES8204739A1 (es) Un procedimiento para preparar compuestos de cefem
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8107231A1 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
JO1351B1 (en) Chemical compounds
HUT50316A (en) Process for production of 1-phenyl-3-naphthyl-oxy-propanamines and pharmaceutical preparations containing them
ES8306160A1 (es) &#34;procedimiento para preparar un nuevo compuesto de cefem&#34;.
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
ES8506729A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
DE3363550D1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof
ES444948A1 (es) Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
ES8504817A1 (es) Un procedimiento para preparar compuestos de cefem.
ES8506707A1 (es) Un derivado de acido tiazolilacetico
ES8105709A1 (es) Un procedimiento para la preparacion de derivados de azeti din-2-ona.
MY103393A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
ES8800140A1 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
JPS554337A (en) Cephalosporin analogs
ES8201531A1 (es) Procedimiento de preparar alcoxi propanolaminas
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
ES2009925A6 (es) Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos.
ES8304923A1 (es) Un procedimiento para la preparacion de un peptido.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.